Other
Statin
0
Pipeline Programs↗
19
Active Trials↗
36
Companies Involved↗
Statin is an early-stage landscape with 0 programs across 36 companies. The most active players are AstraZeneca, Boehringer Ingelheim, Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
227
clinical trials
Completed171 · 75%
Unknown status23 · 10%
Recruiting11 · 5%
Terminated10 · 4%
Not yet recruiting4 · 2%
Active, not recruiting4 · 2%
Other4 · 2%
Clinical Trials
Trial Activity
227 trials
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
Recruiting·—·N/A·NCT06603363·140 enrolled
KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts
Recruiting·—·Phase 1·NCT06469450·15 enrolled
Safety of Bryostatin in Patients With MS
Active, not recruiting·—·Phase 1·NCT06190912·20 enrolled
Page 1 of 16
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)